US EditionPublished • loading... • Updated
The European Commission did not give the public enough information about COVID-19 vaccine deals, EU court says
- The European Commission was criticized for withholding details of Covid vaccine deals by an EU court.
- The court ruled that the commission did not prove disclosing vaccination indemnification details would harm pharmaceutical companies' commercial interests.
- The court also found that the commission failed a "public interest" test by concealing the names of EU officials involved in the deals.
Insights by Ground AI
80 Articles
80 Articles
![Russia Today [🇷🇺-affiliated]](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Fd3a6b2444d4740f3e75a430e54a0cb4d24ee6cc6.jpg%3Fwidth%3D24&w=64&q=75){kind=small}
The judgments relate to contracts concluded between the commission and various pharmaceutical companies in 2020 and 2021. Their value, according to the court, was around 2.7 billion euros, and they made it possible to order more than one billion doses of the covid-19 vaccine.
·Ljubljana, Slovenia
Read Full Article
The judges assert that Brussels did not provide sufficiently comprehensive information to the public, thus annulling “the decisions of the Commission to the extent that they contain irregularities”.
·Portugal
Read Full Article
The EU Commission has suffered a legal defeat in the dispute over its handling of purchase contracts for corona vaccines. According to the EU court, it did not provide sufficient insight into the agreements. By Philip Raillon.
·Hamburg, Germany
Read Full ArticleCoverage Details
Total News Sources80
Leaning Left25Leaning Right13Center12Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 24%
R 26%
![Russia Today [🇷🇺-affiliated]](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Fd3a6b2444d4740f3e75a430e54a0cb4d24ee6cc6.jpg%3Fwidth%3D60&w=128&q=75)
Factuality
To view factuality data please Upgrade to Premium
